Changes to the Code
H.R. 9635 · Getting Innovations to Patients During Shutdowns Act · Introduced The text as a member of Congress first filed it. Most bills never get further than this.
In committee · step 2 of 5
21 U.S.C. § 379h Authority to assess and use drug fees
2 changes the bill asks for here, 2 carried out
- Carried out:
by striking A human drug application and inserting the following:(1) In general.— A human drug application; and
- Carried out:
by adding at the end the following:
(2) Special rule for lapse of appropriations.— (A) In general.— Notwithstanding paragraph (1), during any period for which there is a lapse of appropriations for the programs and activities of the Food and Drug Administration, or for the collection of fees used to support the …
§ 379h(d)–(f)
Start of § 379h to (d)(3)(A) unchanged ·
(B) Waiver of application fee The Secretary shall waive under paragraph (1)(C) the application fee for the first human drug application that a small business or its affiliate submits to the Secretary for review. After a small business or its affiliate is granted such a waiver, the small business or its affiliate shall pay application fees for all subsequent human drug applications submitted to the Secretary for review in the same manner as an entity that does not qualify as a small business.
(e) Effect of failure to pay fees
(1) [inserted: In general.—] [inserted: A human drug application or supplement submitted by a person subject to fees under subsection (a) shall be considered incomplete and shall not be accepted for filing by the Secretary until all such fees owed by such person have been paid.]
(2) [inserted: Special rule for lapse of appropriations.—]
(A) [inserted: In general.—] [inserted: Notwithstanding paragraph (1), during any period for which there is a lapse of appropriations for the programs and activities of the Food and Drug Administration, or for the collection of fees used to support the process for the review of drug applications, the Secretary—]
(i) [inserted: may accept for filing an application or supplement described in paragraph (1) if the application or supplement is complete except for the payment of a fee required under subsection (a); and]
(ii) [inserted: shall extend the deadline for the payment of such fee to the date that is 7 days after the last day of such period.]
(B) [inserted: Effect of failure to pay fees on or before extended deadline date.—] [inserted: If the Secretary accepts an application or supplement subject to an extended deadline for the payment of a fee under subparagraph (A), and the person subject to the fee does not pay the fee on or before the date of the extended deadline—]
(i) [inserted: the Secretary shall consider the application or supplement to be incomplete and deem the application or supplement not accepted; and]
(ii) [inserted: in no case shall the Secretary clear, authorize, or approve the application or supplement (or any related application or supplement) until such fee is paid.]
[struck: A human drug application or supplement submitted by a person subject to fees under subsection (a) shall be considered incomplete and shall not be accepted for filing by the Secretary until all such fees owed by such person have been paid.]
(f) Limitations
(1) In general Fees under subsection (a) shall be refunded for a fiscal year beginning after fiscal year 1997 unless appropriations for salaries and expenses of the Food and Drug Administration for such fiscal year (excluding the amount of fees appropriated for such fiscal year) are equal to or greater than the amount of appropriations for the salaries and expenses of the Food and Drug Administration for the fiscal year 1997 (excluding the amount of fees appropriated for such fiscal year) multiplied by the adjustment factor applicable to the fiscal year involved.
Rest of § 379h unchanged ·
21 U.S.C. § 379j Authority to assess and use device fees
2 changes the bill asks for here, 2 carried out
- Carried out:
by striking A premarket application and inserting the following:(A) In general.— A premarket application; and
- Carried out:
by adding at the end the following:
(B) Special rule for lapse of appropriations.— (i) In general.— Notwithstanding subparagraph (A), during any period for which there is a lapse of appropriations for the programs and activities of the Food and Drug Administration, or for the collection of fees used to support the …
§ 379j(e)–(g)
Start of § 379j to (e)(2)(C) unchanged ·
(D) Request for reduction An applicant seeking a fee reduction under this subsection shall submit supporting information to the Secretary at least 60 days before the fee is required pursuant to subsection (a). The decision of the Secretary regarding whether an entity qualifies for such a reduction is not reviewable.
(f) Effect of failure to pay fees
(1) No acceptance of submissions
(A) [inserted: In general.—] [inserted: A premarket application, premarket report, supplement, premarket notification submission, 30-day notice, request for classification information, periodic reporting concerning a class III device, or de novo classification request submitted by a person subject to fees under subsections (a)(2) and (a)(3) shall be considered incomplete and shall not be accepted by the Secretary until all such fees owed by such person have been paid.]
(B) [inserted: Special rule for lapse of appropriations.—]
(i) [inserted: In general.—] [inserted: Notwithstanding subparagraph (A), during any period for which there is a lapse of appropriations for the programs and activities of the Food and Drug Administration, or for the collection of fees used to support the process for the review of device applications, the Secretary—]
(I) [inserted: may accept a submission described in subparagraph (A) if the submission is complete except for the payment of a fee required under subsection (a)(2) or (a)(3) relating to the submission; and]
(II) [inserted: shall extend the deadline for the payment of such fee to the date that is 7 days after the last day of such period.]
(ii) [inserted: Effect of failure to pay fees on or before extended deadline date.—] [inserted: If the Secretary accepts a submission subject to an extended deadline for the payment of a fee under clause (i), and the person subject to the fee does not pay the fee on or before the date of the extended deadline—]
(I) [inserted: the Secretary shall deem the submission not accepted; and]
(II) [inserted: in no case shall the Secretary clear, authorize, or approve the submission (or any related submission) until such fee is paid.]
[struck: A premarket application, premarket report, supplement, premarket notification submission, 30-day notice, request for classification information, periodic reporting concerning a class III device, or de novo classification request submitted by a person subject to fees under subsections (a)(2) and (a)(3) shall be considered incomplete and shall not be accepted by the Secretary until all such fees owed by such person have been paid.]
(2) No registration Registration information submitted under section 360 of this title by an establishment subject to a registration fee shall be considered incomplete and shall not be accepted by the Secretary until the registration fee under subsection (a)(3) owed for the establishment has been paid. Until the fee is paid and the registration is complete, the establishment is deemed to have failed to register in accordance with section 360 of this title.
(g) Conditions
Rest of § 379j unchanged ·